Keros CSO sells 3,568 shares in tax sell-to-cover
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Keros Therapeutics, Inc. (KROS) reported that Chief Scientific Officer Lorena Raquel Lerner sold 3,568 shares of common stock on 2026-08-18 at a weighted average price of $10.29 per share, in automatic "sell-to-cover" transactions for tax withholding on vesting RSUs. Following these sales, she held 27,559 shares of common stock directly.
Insider Trade Summary
Net Seller: 3,568 shares
Net Sell
1 txn
Insider
Lerner Lorena Raquel
Role
Chief Scientific Officer
Sold
3,568 shs ($37K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 3,568 | $10.29 | $37K |
Holdings After Transaction:
Common Stock — 27,559 shares (Direct)
Footnotes (2)
- F1. The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.14 to $10.50 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Shares sold: 3,568 shares of Common Stock
Weighted average sale price: $10.29 per share
Sale price range: $10.14 to $10.50 per share
+1 more
4 metrics
Shares sold
3,568 shares of Common Stock
Sale on 2026-08-18 by Chief Scientific Officer Lorena Raquel Lerner
Weighted average sale price
$10.29 per share
Weighted average price for 3,568 Keros Therapeutics shares sold
Sale price range
$10.14 to $10.50 per share
Multiple transactions within this price range on 2026-08-18
Shares owned after transaction
27,559 shares of Common Stock
Direct ownership by Lorena Raquel Lerner following the sale
Key Terms
sell-to-cover, restricted stock units, weighted average price, tax withholding obligations
4 terms
sell-to-cover financial
"The Issuer has adopted a "sell-to-cover" policy to satisfy the tax"
Sell-to-cover is when part of newly issued or exercised company stock is immediately sold to pay required taxes and fees, so the recipient keeps the remaining shares. For investors this matters because it reduces the number of shares insiders or employees actually hold after a grant, can create small, routine share sales that aren’t signal of cashing out, and slightly increases share supply on the market—like selling a portion of a paycheck to cover the tax bill.
restricted stock units financial
"obligations in connection with the vesting of restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
tax withholding obligations financial
"shares required to be sold by the Reporting Person to cover tax withholding"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did KROS disclose for Lorena Raquel Lerner?
Keros Therapeutics disclosed that Chief Scientific Officer Lorena Raquel Lerner sold 3,568 shares of common stock on 2026-08-18 in automatic sell-to-cover transactions to satisfy tax withholding obligations related to vesting restricted stock units.
Was the KROS insider sale made under a Rule 10b5-1 trading plan?
The filing does not state that the transactions were made under a Rule 10b5-1 trading plan. Instead, it explains that the sales were automatic sell-to-cover transactions pursuant to the issuer’s policy for tax withholding on vesting restricted stock units.
What type of security was involved in the KROS Form 4 transaction?
The transaction reported for Keros Therapeutics (KROS) involved Common Stock. The 3,568 shares sold were common shares, disposed of to satisfy tax withholding obligations arising from the vesting of restricted stock units held by the reporting person.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates